يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Glucagon-Like Peptide-1 Receptor"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.

    المؤلفون: Pablo Frias, Juan1, Nauck, Michael A.2, Van, Joanna3, Kutner, Mark E.4, Xuewei Cui5, Benson, Charles5, Urva, Shweta5, Gimeno, Ruth E.5, Milicevic, Zvonko6, Robins, Deborah5, Haupt, Axel5 haupt_axel@lilly.com, Frias, Juan Pablo7, Cui, Xuewei8

    المصدر: Lancet. 11/17/2018, Vol. 392 Issue 10160, p2180-2193. 14p.

    مصطلحات موضوعية: *RESEARCH, *STATISTICAL sampling, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide 1, TYPE 2 diabetes treatment, DRUG efficacy, GLYCOSYLATED hemoglobin, BLOOD sugar, COMPARATIVE studies, DRUG administration, HYPOGLYCEMIC agents, IMMUNOGLOBULINS, RESEARCH methodology, MEDICAL cooperation, TYPE 2 diabetes, RECOMBINANT proteins, WEIGHT loss, EVALUATION research, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, GLUCAGON-like peptides


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

    المؤلفون: Harmony Outcomes committees and investigators, Hernandez, Adrian F.1, Green, Jennifer B.1, Granger, Christopher B.1, Rosenberg, Anne E.1, Sigmon, Kristina N.1, Janmohamed, Salim2, Jones, Nigel P.2, Thorpe, Karl M.2, D'Agostino Sr., Ralph B.3, Leiter, Lawrence A.4, Somerville, Matthew C.5, McMurray, John J. V.6, Del Prato, Stefano7, D'Agostino, Ralph B Sr8

    المصدر: Lancet. 10/27/2018, Vol. 392 Issue 10157, p1519-1529. 11p.

    مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, TYPE 2 diabetes risk factors, CARDIOVASCULAR disease prevention, CARDIOVASCULAR diseases risk factors, MYOCARDIAL infarction risk factors, SODIUM-glucose cotransporters, TYPE 2 diabetes complications, STROKE prevention, SUBCUTANEOUS injections, CARDIOVASCULAR diseases, COMPARATIVE studies, DRUG administration, HYPOGLYCEMIC agents, MYOCARDIAL infarction, TYPE 2 diabetes, STROKE, GLUCAGON-like peptide 1, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, KAPLAN-Meier estimator, PREVENTION, THERAPEUTICS


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

    المؤلفون: Holst, Jens Juul1 (AUTHOR) jjholst@sund.ku.dk

    المصدر: Lancet. Jul2019, Vol. 394 Issue 10192, p4-6. 3p.

    مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

    المؤلفون: Mafham, Marion1, Preiss, David1

    المصدر: Lancet. 10/27/2018, Vol. 392 Issue 10157, p1489-1490. 2p.

    مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, CARDIOVASCULAR disease treatment

    الشركة/الكيان: GLAXOSMITHKLINE

    People: HERNANDEZ, Adrian


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Type 2 diabetes: which drug as add-on to metformin?

    المؤلفون: Madsbad, Sten1 sten.madsbad@hvh.regionh.dk

    المصدر: Lancet. 6/16/2012, Vol. 379 Issue 9833, p2222-2223. 2p.

    مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, TYPE 2 diabetes, INSULIN, HYPERTENSION, HEART diseases, GLUCAGON


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

    المؤلفون: Garvey, W Timothy1 (AUTHOR) garveyt@uab.edu, Frias, Juan P2 (AUTHOR), Jastreboff, Ania M3 (AUTHOR), le Roux, Carel W4,5 (AUTHOR), Sattar, Naveed6 (AUTHOR), Aizenberg, Diego7 (AUTHOR), Mao, Huzhang8 (AUTHOR), Zhang, Shuyu8 (AUTHOR), Ahmad, Nadia N8 (AUTHOR), Bunck, Mathijs C8 (AUTHOR), Benabbad, Imane8 (AUTHOR), Zhang, Xiaotian M8 (AUTHOR)

    المصدر: Lancet. Aug2023, Vol. 402 Issue 10402, p613-626. 14p.

    مصطلحات موضوعية: TYPE 2 diabetes, CLINICAL trials, GLUCAGON-like peptide-1 receptor, TERMINATION of treatment, WEIGHT loss

    الشركة/الكيان: ELI Lilly & Co. LLY


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Choosing a blood-glucose-lowering agent after metformin.

    المؤلفون: Diamant, Michaela1 m.diamant@vumc.nl

    المصدر: Lancet. 6/16/2012, Vol. 379 Issue 9833, p2220-2221. 2p.

    مصطلحات موضوعية: METFORMIN, TREATMENT of diabetes, BLOOD sugar, GLUCAGON-like peptide-1 receptor, INSULIN, WEIGHT gain


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?

    المؤلفون: Rayner, Christopher K.1,2, Horowitz, Michael1,3

    المصدر: Lancet. 6/30/2018, Vol. 391 Issue 10140, p2577-2578. 2p. 1 Color Photograph.

    مصطلحات موضوعية: *PEPTIDE hormones, *TYPE 2 diabetes, *BARIATRIC surgery, *GLUCAGON, *GLUCAGON-like peptide-1 receptor, *PANCREAS


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث